Literature DB >> 17659840

The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles.

Akira Kobata1.   

Abstract

In contrast to other serum glycoproteins, the majority of the N-linked sugar chains of human serum IgG are not sialylated. In addition, extremely high micro-heterogeneity occurs in the serum IgG sugar chains. This micro-heterogeneity is mainly produced by the presence or absence of the two galactoses, the bisecting GlcNAc, and the fucose residue. Interesting evidence is that the molar ratio of each sugar chain of the serum IgG samples is quite constant in healthy individuals. By adding the information of the characteristic feature of the sugar patterns of myeloma IgG samples and glycosylated Bence Jones proteins, which are the products of monoclonal B-cells, it was proposed that B-cells in the human blood are a mixture of clones equipped with different sets and ratios of glycosyltransferases. It was also proposed that each glycoform of IgG might have a different function. This hypothesis was realized by the comparative studies of the function of IgG samples before and after removal of galactose residues, fucose residue, or sialic acid residues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659840     DOI: 10.1016/j.bbagen.2007.06.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.

Authors:  Sybille Böhm; Inessa Schwab; Anja Lux; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

2.  Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.

Authors:  Martin Svoboda; Benjamin F Mann; John A Goetz; Milos V Novotny
Journal:  Anal Chem       Date:  2012-03-13       Impact factor: 6.986

3.  Decreased Immunoglobulin G Core Fucosylation, A Player in Antibody-dependent Cell-mediated Cytotoxicity, is Associated with Autoimmune Thyroid Diseases.

Authors:  Tiphaine C Martin; Mirna Šimurina; Marta Ząbczyńska; Marina Martinic Kavur; Magdalena Rydlewska; Marija Pezer; Kamila Kozłowska; Andrea Burri; Marija Vilaj; Renata Turek-Jabrocka; Milena Krnjajić-Tadijanović; Małgorzata Trofimiuk-Müldner; Ivo Ugrina; Anna Lityńska; Alicja Hubalewska-Dydejczyk; Irena Trbojevic-Akmacic; Ee Mun Lim; John P Walsh; Ewa Pocheć; Tim D Spector; Scott G Wilson; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2020-02-05       Impact factor: 5.911

4.  Immunoglobulin G1 Fc domain motions: implications for Fc engineering.

Authors:  Martin Frank; Ross C Walker; William N Lanzilotta; James H Prestegard; Adam W Barb
Journal:  J Mol Biol       Date:  2014-02-09       Impact factor: 5.469

Review 5.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

6.  Building a PGC-LC-MS N-glycan retention library and elution mapping resource.

Authors:  Jodie L Abrahams; Matthew P Campbell; Nicolle H Packer
Journal:  Glycoconj J       Date:  2017-09-13       Impact factor: 2.916

7.  The Structural Role of Antibody N-Glycosylation in Receptor Interactions.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  Structure       Date:  2015-07-23       Impact factor: 5.006

Review 8.  Site-specific linking of biomolecules via glycan residues using glycosyltransferases.

Authors:  Pradman K Qasba; Elizabeth Boeggeman; Boopathy Ramakrishnan
Journal:  Biotechnol Prog       Date:  2008-04-22

Review 9.  Mammalian glycosylation in immunity.

Authors:  Jamey D Marth; Prabhjit K Grewal
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

10.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.